Treatment with BA also inhibited key cellular signaling pathways associated with ADPKD cellular proliferation (mTOR and ERK) (Saigusa and Bell, 2015) and sharply reduced the kidney injury marker KIM1 and, to a lesser extent, NGAL (Figure 8). Here, HAVCR1 is linked to autosomal dominant polycystic kidney disease.